Our leadership team, including recognized physician experts and researchers, is at the forefront of shaping new standards of cancer care based upon the latest research. Patients are at the heart of everything we do. Sarah Cannon offers integrated cancer services, providing patients with cutting-edge treatments and upholding the highest quality care for patients from diagnosis through survivorship.
John D. Hainsworth, MD
Co-Founder; Principal Investigator
Hainsworth founded Sarah Cannon Research Institute in 1993 along with F. Anthony Greco, MD to create the first community-based clinical trial program outside of an academic setting. He currently coordinates the Sarah Cannon Research Institute clinical trials program in genitourinary cancer, and is also broadly involved with protocol development, data analysis and manuscript preparation in the Phase II/III clinical trials programs.